Clinical Trials Logo

Clinical Trial Summary

The primary aim of this trial is to compare the effect of acetated ringer's solution with that of saline for therapy on the incidence and development of major adverse renal events among septic shock patients. The investigators hypothesize that use of acetated ringer's solution for resuscitation among septic shock patients will reduce the incidence of major adverse kidney events.


Clinical Trial Description

Normal saline and Ringer's solutions are the preferred crystalloid fluids administered in early septic shock. However, evidence have associated saline with hyperchloremia and secondary metabolic acidosis, and renal vasoconstriction, increased incidence of acute kidney injury (AKI) and mortality. The primary aim of this trial is to compare the effect of acetated ringer's solution with that of saline for therapy on the incidence and development of major adverse renal events among septic shock patients. The investigators hypothesize that use of acetated ringer's solution for resuscitation among septic shock patients will reduce the incidence of major adverse kidney events. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04507672
Study type Interventional
Source Southeast University, China
Contact
Status Not yet recruiting
Phase N/A
Start date September 1, 2020
Completion date December 1, 2023

See also
  Status Clinical Trial Phase
Completed NCT03788837 - Ilomedin in Septic Shock With Persistent Microperfusion Defects (I-MICRO) Phase 3